| Literature DB >> 28877567 |
Sara Nemati1, Asghar Fazaeli1, Homa Hajjaran2, Ali Khamesipour3, Mohsen Falahati Anbaran4, Arezoo Bozorgomid2, Fatah Zarei5.
Abstract
Despite the broad distribution of leishmaniasis among Iranians and animals across the country, little is known about the genetic characteristics of the causative agents. Applying both HSP70 PCR-RFLP and sequence analyses, this study aimed to evaluate the genetic diversity and phylogenetic relationships among Leishmania spp. isolated from Iranian endemic foci and available reference strains. A total of 36 Leishmania isolates from almost all districts across the country were genetically analyzed for the HSP70 gene using both PCR-RFLP and sequence analysis. The original HSP70 gene sequences were aligned along with homologous Leishmania sequences retrieved from NCBI, and subjected to the phylogenetic analysis. Basic parameters of genetic diversity were also estimated. The HSP70 PCR-RFLP presented 3 different electrophoretic patterns, with no further intraspecific variation, corresponding to 3 Leishmania species available in the country, L. tropica, L. major, and L. infantum. Phylogenetic analyses presented 5 major clades, corresponding to 5 species complexes. Iranian lineages, including L. major, L. tropica, and L. infantum, were distributed among 3 complexes L. major, L. tropica, and L. donovani. However, within the L. major and L. donovani species complexes, the HSP70 phylogeny was not able to distinguish clearly between the L. major and L. turanica isolates, and between the L. infantum, L. donovani, and L. chagasi isolates, respectively. Our results indicated that both HSP70 PCR-RFLP and sequence analyses are medically applicable tools for identification of Leishmania species in Iranian patients. However, the reduced genetic diversity of the target gene makes it inevitable that its phylogeny only resolves the major groups, namely, the species complexes.Entities:
Keywords: HSP70; Iran; Leishmania infantum; Leishmania major; Leishmania tropica; PCR-RFLP; leishmaniasis; phylogenetic analysis
Mesh:
Substances:
Year: 2017 PMID: 28877567 PMCID: PMC5594730 DOI: 10.3347/kjp.2017.55.4.367
Source DB: PubMed Journal: Korean J Parasitol ISSN: 0023-4001 Impact factor: 1.341
Details of the original and GenBank Leishmania isolates used in the present study
| No. | Sample ID | Species | Locality | Host | Disease | Sample ID | Species | Locality |
|---|---|---|---|---|---|---|---|---|
| 1 | LM4 | Esfahan | Human | CL | JN628986.1 | Georgia | ||
| 2 | LM5 | Ardestan | Human | CL | JN676923 | Georgia | ||
| 3 | LM6 | Mashhad | Human | CL | JX021443 | China | ||
| 4 | LM7 | Sistan Baluchestan | Human | CL | JX021433 | China | ||
| 5 | LM8 | Shiraz | Human | CL | JX021432 | China | ||
| 6 | LM10 | Agha Aliabas | Human | CL | FN395025 | India | ||
| 1 | LM12 | Esfahana | Human | CL | FN395026 | Kenya | ||
| 5 | LM13 | Shiraz | Human | CL | FN395022 | Sudan | ||
| 5 | LM14 | Shiraz | Human | CL | FN395023 | Israil | ||
| 7 | LM28 | Dehloran | Human | CL | FN395024 | Kenya | ||
| 8 | LM29 | Ilam | Human | CL | XM001684512 | Israel | ||
| 8 | LM30 | Ilam | Human | CL | FN395031 | Malta | ||
| 9 | LM31 | Golestan | Human | CL | FN395032 | Portugal | ||
| 10 | LM36 | Bandar_Abbas | Human | CL | FN395033 | Malta | ||
| 11 | LT27 | Kermanshah | Human | CL | XM001470287 | Spain | ||
| 3 | LT | Mashhad | Human | CL | GU071173 | Brazil | ||
| 12 | LT2 | Bam | Human | CL | KG905366 | India | ||
| 12 | LT3 | Bam | Human | CL | GU071178 | Brazil | ||
| 3 | LT16 | Mashhad | Human | CL | HF586354 | Panama | ||
| 17 | LT9 | Afghanistan | Human | CL | HF586353 | Colombia | ||
| 17 | LT19 | Afghanistan | Human | CL | JX312712 | China | ||
| 17 | LT21 | Afghanistan | Human | CL | FN669773 | Ethiopia | ||
| 9 | LT22 | Golestan | Human | CL | GU071174 | Brazil | ||
| 3 | LT25 | Mashhad | Human | CL | HF586413 | Ecuador | ||
| 5 | LT26 | Shiraz | Human | CL | LN907842 | Ecuador | ||
| 13 | L.VT5 | Ardebil | Human | CL | FN395056 | Brazil | ||
| 14 | L.VT6 | Tehran | Human | CL | FN395055 | Panama | ||
| 15 | LI.1 | Meshkin Shahr | Canine | VL | HF586367 | Panama | ||
| 15 | LI.2 | Meshkin Shahr | Canine | VL | HF586368 | Peru | ||
| 15 | LI.3 | Meshkin Shahr | Canine | VL | FN395044 | Peru | ||
| 15 | LI.7 | Meshkin Shahr | Canine | VL | GU071175 | Brazil | ||
| 15 | LI.8 | Meshkin Shahr | Canine | VL | HF586356 | China | ||
| 16 | L4 | Hamedan | Rodent | JX021442 | China | |||
| 16 | L5 | Hamedan | Rodent | FN395037 | Brazil | |||
| 16 | L38 | Hamedan | Rodent | FN395036 | Brazil | |||
| 16 | L40 | Hamedan | Rodent | FN395035 | Brazil | |||
| JN628988 | Georgia | HF586355 | China | |||||
| JN628987 | Georgia | EF108422 | Honduras |
Locality number on Fig. 1.
Original Leishmania strains from different districts of Iran.
Strains studied by other researchers, taken from NCBI.
Fig. 1Map of Iran, showing our sampling localities. Locality numbers are the same as in Table 1.
Fig. 2Agarose gel (3%) showing 3 HSP70 PCR-RFLP profiles for Leishmania reference strains after digestion with HaeIII. Lane1, L. tropica; lane 2, L. tropica; lane 3, L. major; lane 4, L. major, lane 5, L. infantum; lane 6, L. infantum; lane M, 100-bp size marker.
Fig. 3ML tree summarizing the relationship between HSP70 sequences of Leishmania species. Bootstrap resampling values are provided at each fork (given only if ≥40%). Iranian isolates are represented by circle (L. major), triangle (L. tropica), and square (L. infantum) symbols.
Basic parameters of genetic diversity and neutrality tests, for 3 Iranian Leishmania species
| Species | Diversity parameters | Neutrality tests | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| N | S | H | Parsimony informative sites | Singleton variable sites | h±SD | π | Tajima’s D | Fu’s Fs | |
| 20 | 10 | 3 | 1 | 9 | 0.195±0.11 | 0.00093 | −2.14 | 1.42 | |
|
| |||||||||
| 11 | 2 | 2 | 2 | 0 | 0.436±0.13 | 0.00075 | 0.85 | 2.01 | |
|
| |||||||||
| 5 | 0 | 1 | 0 | 0 | 0.00±0.00 | 0.0000 | N.A. | N.A. | |
No. of sequences.
No. of polymorphic sites.
No. of haplotypes.
Haplotype diversity (h±SD).
Nucleotide diversity.
P<0.05.
Not available.